PharmaVentures Advises Stericool on Sale to Sweden's Getinge Group

17 Dec, 2015, 04:00 ET from PharmaVentures

OXFORD, England, December 17, 2015 /PRNewswire/ --

PharmaVentures is pleased to announce that it acted as advisor to Stericool on its sale to Sweden's Getinge Group, a global leader in infection control and contamination prevention solutions.

Stericool specialises in hydrogen peroxide based solution low temperature sterilizers for emerging markets. Founded in 2008, Stericool has its headquarters and manufacturing site in Ankara, Turkey. The acquisition will be included under Getinge's new business category unit Surgical Workflows and will increase potential for growth in East/ South Europe and the rest of the world.

Fintan Walton, Chief Executive of PharmaVentures said: "This is another important cross-border result for one of our clients. PharmaVentures continues to provide valuable advisory services across healthcare M&A and Licensing."

Ping Shek, Vice President of PharmaVentures said: "Medical device and healthcare equipment groups remain active in M&A as adding complementary businesses to their global platforms augments organic growth."

For over 23 years, PharmaVentures has acted as advisor to over 700 pharmaceutical and biotechnology clients in transactions; covering licensing, mergers, acquisitions, divestments and joint venture activities for companies. 

About PharmaVentures 

PharmaVentures is a premier transaction advisory firm; a leader in partnering, M&A deals and strategic alliances. Our unrivalled bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes us uniquely placed to support your business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest.

Find out more http://www.pharmaventures.com

Our services include:

  • M&A (divestments, mergers, acquisitions and strategic transactions)
  • Strategy (commercialisation, deal strategy, due diligence, market entry)
  • Valuation and Positioning (licensing, M&A, fund raising & expert testimonies)
  • Licensing (in and out licensing)
  • Expert Testimony (patent infringement, deal disagreements, taxation, determining damages)

Now in its 24th year, PharmaVentures is based in Oxford, UK, and employs over 20 professionals and has associates in N. America, Latin America, and Asia-Pacific.

SOURCE PharmaVentures